Cochrane Abstracts
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"CFTR Modulator Monotherapy for People With Cystic Fibrosis With Class II CFTR Gene Variants (most Commonly F508del)." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440911/all/CFTR_modulator_monotherapy_for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_.
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del). Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440911/all/CFTR_modulator_monotherapy_for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_. Accessed August 10, 2026.
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del). (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440911/all/CFTR_modulator_monotherapy_for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_
CFTR Modulator Monotherapy for People With Cystic Fibrosis With Class II CFTR Gene Variants (most Commonly F508del) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 August 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440911/all/CFTR_modulator_monotherapy_for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
ID - 440911
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440911/all/CFTR_modulator_monotherapy_for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
